ALPS Advisors »

Candel Therapeutics shares owned by ALPS Advisors

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $255k 45k 5.65
2025-09-30 $134k 26k 5.10
2025-06-30 $137k 27k 5.06